Clinical Trial Update: Study of Pomalidomide, Cyclophosphamide, Dexamethasone in Relapsed/Refractory Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pomalidomide with cyclophosphamide and dexamethasone in relapsed/refractory multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Pomalidomide/Cyclophosphamide/Dexamethasone

Snippet

Sponsor: Ajai Chari | Conditions: Multiple Myeloma in Relapse, Multiple Myeloma, Refractory | Phase 2 | Status: COMPLETED